Migraine Nasal Spray Market Size

  • Report ID: 4059
  • Published Date: Sep 16, 2024
  • Report Format: PDF, PPT

Migraine Nasal Spray Market Size

Migraine Nasal Spray Market size was over USD 502.18 million in 2023 and is poised to cross USD 1.18 billion by the end of 2036, witnessing more than 6.8% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of migraine nasal spray is estimated at USD 529.5 million.

The market growth can be attributed to growing prevalence of migraine, backed by the increased stress, depression, sleep deprivation, and anxiety prevalent amongst the population. In fact, migraine is the third most common disease, and approximately 1 billion people suffer from migraine worldwide. Furthermore, scientists suggest that humans are facing extreme weather changes, which can aggravate their health, making diseases, such as, migraine a common phenomenon. According to the World Meteorological Organisation, [R1] the decade 2011-2020 was the warmest on record, and the year 2020 is among the three warmest years globally. The increasing adulteration in food, hormonal misbalance, and longer screen time are also major reasons behind the growing number of migraine patients. Scientists have also found that migraine is more pervasive in women owing to hormonal changes, as 8 out of 10 people with migraine are women. As the number of patients with migraine is increasing exponentially, people are seeking an efficient remedy to eradicate the excruciating pain, which is expected to expand the global migraine nasal spray market.


Migraine-Nasal-Spray-Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4059
  • Published Date: Sep 16, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The exponentially increasing number of migraine patients worldwide is the leading cause of the widening demand for migraine nasal sprays.

The market is anticipated to attain a notable CAGR over the forecast period, i.e., 2022-2031.

People often experience side effects such as unusual taste in the mouth, dizziness, and dry eyes. These adverse effects are estimated to hamper the market growth.

North America region is estimated to provide a good business opportunity for the market on account of good healthcare infrastructure and rising awareness among people.

The major players in the market are Upsher-Smith Laboratories, AstraZeneca plc, GlaxoSmithKline plc, Cipla Inc, Dr. Reddy’s Laboratories Ltd, Assertio Therapeutics, Inc., and Impel Neuro Pharma. Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample